A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with ...

A large propensity-matched retrospective cohort study showed a small but statistically significant 7% increase in new-onset ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future ...

ORLANDO ‑- Cataract surgery was linked to an increased risk of conversion from dry to neovascular (wet) age-related macular ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Lilly’s upfront offer for Adverum, the developer of a gene therapy for age-related macular degeneration, is less than the ...

Astellas Pharma (($ALPMF)) announced an update on their ongoing clinical study. Astellas Pharma is conducting a clinical study titled ‘A Phase ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is ...